Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview

Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview

Docetaxel (DCX) is a highly effective chemotherapeutic drug used in the treatment of different types of cancer, including non-small cell lung cancer (NSCLC). The drug is known to have low oral bioavailability due to its low aqueous solubility, poor membrane permeability and susceptibility to hepatic...

Full description

Bibliographic Details
Main Authors: S. Aishah A. Razak, Habibah A. Wahab, Faisalina Ahmad Fisol, Ibrahim M. Abdulbaqi, Thaigarajan Parumasivam, Noratiqah Mohtar, Amirah Mohd Gazzali
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
docetaxel
nanoparticles
lung cancer
drug delivery
non-small cell lung cancer (NSCLC)
Online Access:https://www.mdpi.com/2072-6694/13/3/400

Internet

https://www.mdpi.com/2072-6694/13/3/400

Similar Items